These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3696784)
1. [Recent progress in the treatment and prognosis of congenital cardiopathies in early infancy]. Marcelletti C; Squitieri C; di Donato R Pathologica; 1986; 78(1058):731-43. PubMed ID: 3696784 [No Abstract] [Full Text] [Related]
3. [Prostaglandins in the care of the neonate with heart defects]. Samánek M; Hruda P Cesk Pediatr; 1987 Feb; 42(2):71-6. PubMed ID: 3568178 [No Abstract] [Full Text] [Related]
4. The hypoplastic left heart syndrome - a treatable condition. Westerman GR; Norton JB; Van Devanter SH J Ark Med Soc; 1984 Jan; 80(8):367-70. PubMed ID: 6229522 [No Abstract] [Full Text] [Related]
5. [The newborn infant with a heart defect--diagnostic and therapeutic procedures]. Schöber JG; Bühlmeyer K Monatsschr Kinderheilkd; 1984 Jun; 132(6):387-90. PubMed ID: 6472288 [No Abstract] [Full Text] [Related]
6. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects]. Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203 [No Abstract] [Full Text] [Related]
7. [Perfusion with prostaglandins (PGE) in newborn infants with acute cardiopathy]. Moreno F; Burgueros M; Herraiz I; Quero C; Sánchez PA; Omeñaca F; Martínez A Rev Esp Cardiol; 1978; 31(3):335-8. PubMed ID: 674795 [No Abstract] [Full Text] [Related]
8. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1]. Fujii S; Nagai I; Yonei A; Sari A; Baba K Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818 [No Abstract] [Full Text] [Related]
9. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease. Linday LA; Engle MA Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040 [No Abstract] [Full Text] [Related]
10. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2. Olley PM; Coceani F Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917 [No Abstract] [Full Text] [Related]
13. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn. Olley PM; Coceani F; Rowe RD; Swyer PR Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235 [No Abstract] [Full Text] [Related]
14. Use of prostaglandins in cardiopulmonary diseases of the newborn. Olley PM; Coceani F Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504 [No Abstract] [Full Text] [Related]
16. Indications and pharmacological effects of therapy with prostaglandin E1 in the newborn. Schöber JG; Kellner M; Mocellin R; Schumacher G; Bühlmeyer K Adv Prostaglandin Thromboxane Res; 1980; 7():905-11. PubMed ID: 7369055 [No Abstract] [Full Text] [Related]
18. [Value of prostaglandin E1 in cardiac malformations in the newborn infant]. Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667 [TBL] [Abstract][Full Text] [Related]
19. [Emergency cardiology during the first year of life]. Real FJ Thoraxchir Vask Chir; 1970 Aug; 18(4):286-90. PubMed ID: 5273036 [No Abstract] [Full Text] [Related]
20. Prostaglandin E1 infusion: successful initial treatment. Linday L; Levin AR; Reitman M; Engle MA N Y State J Med; 1981 Feb; 81(2):218-21. PubMed ID: 6936640 [No Abstract] [Full Text] [Related] [Next] [New Search]